Purpose: After resuscitation from out-of-hospital cardiac arrest (OHCA), renal injury and hemodynamic instability are common. We aimed to assess the association between low cardiac output during targeted temperature management (TTM) and acute kidney injury (AKI) after OHCA.

Materials And Methods: Single-center substudy of 171 patients included in the prospective, randomized TTM-trial. Hemodynamic evaluation was performed with serial measurements by pulmonary artery catheter. AKI was the primary endpoint and was defined according to the KDIGO-criteria.

Results: Of 152 patients with available hemodynamic data, 49 (32%) had AKI and 21 (14%) had AKI with need for renal replacement therapy (RRT) in the first three days. During targeted temperature management, patients with AKI had higher heart rate (11 beats/min, p < 0.0001), higher mean arterial pressure (MAP) (4 mmHg, p = 0.001) and higher lactate (1 mmol/L, p < 0.0001) compared to patients without AKI. However, there was no difference in cardiac index (p = 0.25). In a multivariate logistic regression model, adjusting for potential confounders, MAP (p = .03), heart rate (p = .01) and lactate (p = .006), but not cardiac output, were independently associated with AKI.

Conclusions: Blood pressure, heart rate and lactate, but not cardiac output, during 24 h of TTM were associated with AKI in comatose OHCA-patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrc.2019.07.013DOI Listing

Publication Analysis

Top Keywords

targeted temperature
12
temperature management
12
cardiac output
8
output targeted
8
out-of-hospital cardiac
8
cardiac arrest
8
aki
5
cardiac
4
management renal
4
renal function
4

Similar Publications

Background: Limited information is available regarding the changes in blood culture utilization following the COVID-19 pandemic. Blood culture utilization rate is a critical indicator of diagnostic efficiency for infectious diseases. This study aims to describe the impact of the COVID-19 pandemic on blood culture utilization rate in Shanghai.

View Article and Find Full Text PDF

The recent emergence of bile salt hydrolase (BSH) enzyme as a therapeutic target reflects its unbound potential in mitigating hypercholesterolemia, obesity, and gastrointestinal issues. However, to bolster its industrial application, optimization of BSH assay lays the cornerstone for enhancing sensitivity, specificity, and reproducibility. The current study delved into optimizing the BSH assay parameters utilizing response surface methodology (RSM) and one-factor-at-a-time (OFAT) method for two novel, natural BSH producers, Heyndrickxia coagulans ATCC 7050 and Lactiplantibacillus plantarum ATCC 10012.

View Article and Find Full Text PDF

Modeling suction of unsaturated granular soil treated with biochar in plant microbial fuel cell bioelectricity system.

Sci Rep

January 2025

Departamento de Ciencias de la Construcción, Facultad de Ciencias de la Construcción Ordenamiento Territorial, Universidad Tecnológica Metropolitana, Santiago, Chile.

There is an initiative driven by the carbon-neutrality nature of biochar in recent times, where various countries across Europe and North America have introduced perks to encourage the production of biochar for construction purposes. This objective aligns with the zero greenhouse emission targets set by COP27 for 2050. This research work seeks to assess the effectiveness of biochar in soils with varying grain size distributions in enhancing the soil-water characteristic curve (SWCC).

View Article and Find Full Text PDF

DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1 T-Lineage Cancers.

ACS Appl Mater Interfaces

January 2025

Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.

Selective therapeutic targeting of T-cell malignancies is difficult due to the shared lineage between healthy and malignant T cells. Current front-line chemotherapy for these cancers is largely nonspecific, resulting in frequent cases of relapsed/refractory disease. The development of targeting approaches for effectively treating T-cell leukemia and lymphoma thus remains a critical goal for the oncology field.

View Article and Find Full Text PDF

Triple-action cancer therapy using laser-activated NO-releasing metallomicellar nanophotosensitizer for pyroptosis-driven immune reprogramming.

J Control Release

January 2025

Department of Biomedical Sciences and BioMedical Sciences Graduate Program (BMSGP), Chonnam National University Medical School, Gwangju 61469, Republic of Korea; DR Cure Inc., Hwasun 58128, Republic of Korea. Electronic address:

Cancer photoimmunotherapy represents an intelligent and highly efficient therapeutic approach that harnesses the photothermal effect to precisely target and ablate tumor tissues, while simultaneously modulating the immune system to achieve tumor elimination. The integration of multifunctional therapeutic modalities for combined photoimmunotherapy requires advanced drug delivery systems. However, the design of a single nanoagent capable of serving as a multifunctional nanophotosensitizer remains a significant challenge.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!